Empirical antimicrobial therapy received (n = 210)
| Parameter | Frequency (%) |
|---|---|
| Empiric antibiotics received | |
| Yes | 210 (100.0) |
| No | 0 (0) |
| Number of empiric antibiotics received | |
| 1 | 44 (21.0) |
| 2 | 93 (44.3) |
| 3 | 49 (23.3) |
| ≥ 4 | 24 (11.4) |
| Route of administration# | |
| Intravenous | 206 (98.1) |
| Oral | 166 (79.0) |
| Topical | 4 (1.9) |
# Patients could receive antibiotics via more than one route of administration, which is why the percentages for each route do not necessarily sum to 100%
The supplementary table for this article are available at: https://www.explorationpub.com/uploads/Article/file/1001312_sup_1.pdf.
SS: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing—original draft, Writing—review & editing. RI: Conceptualization, Investigation, Methodology, Validation, Visualization, Writing—original draft, Writing—review & editing. KAH: Conceptualization, Data curation, Methodology, Validation, Visualization, Writing—original draft, Writing—review & editing. RKAF: Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Supervision, Validation, Visualization, Writing—original draft, Writing—review & editing.
The authors declare that they have no conflicts of interest.
The research protocol was approved by the Institutional Review Board at JUH (Approval number R023/28293).
Due to the retrospective nature of the study, direct patient contact was not involved. Consequently, informed consent was not required for this study.
Not applicable.
Required information can be available upon request from the corresponding author (Rana Abu-Farha, r_abufarha@asu.edu.jo).
Not applicable.
© The Author(s) 2025.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.